PMC:7536954 / 4080-4291
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T54 | 118-120 | Disease | denotes | HS | http://purl.obolibrary.org/obo/MONDO_0006559 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T25 | 37-43 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
| T26 | 55-60 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | label |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T36 | 55-60 | Chemical | denotes | label | http://purl.obolibrary.org/obo/CHEBI_35209 |
| T37 | 118-120 | Chemical | denotes | HS | http://purl.obolibrary.org/obo/CHEBI_74056 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 167 | 121-129 | Species | denotes | patients | Tax:9606 |
| 171 | 8-19 | Chemical | denotes | Secukinumab | MESH:C555450 |
| 172 | 163-174 | Chemical | denotes | secukinumab | MESH:C555450 |
| 173 | 200-210 | Chemical | denotes | adalimumab | MESH:D000068879 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T42 | 118-120 | Phenotype | denotes | HS | http://purl.obolibrary.org/obo/HP_0040154 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T38 | 0-211 | Sentence | denotes | 2 , 3 Secukinumab was successfully tested in an open‐label trial at two different doses that showed the majority of HS patients achieving HiSCR, suggesting that secukinumab could be as effective as adalimumab. |